Mask Up: How To Protect Your Respiratory System From Wildfire Smoke
Drug Topics
JUNE 8, 2023
Which masks (if any) serve as the best protection against wildfire smoke, and what do experts say about home appliances like air conditioners?
Thu.Jun 08, 2023
465 
Highlights from ASCO 2023
PhRMA
JUNE 8, 2023
Last week, I traveled to the American Society of Clinical Oncology’s (ASCO) annual meeting. It’s always an exceptional meeting where the brightest minds in oncology, including researchers, health care providers and industry stakeholders gather to learn about the latest advancements in cancer research and development (R&D).
Join 5,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
NCCN Calls on Federal Agencies, Payers, to Take Action on Chemotherapy Drug Shortages
Drug Topics
JUNE 8, 2023
Carboplatin and cisplatin are currently in short supply.
Yes, biopharma still has a reputation problem. These leaders are looking for solutions
PharmaVoice
JUNE 8, 2023
Negative news is breaking down the public’s perception of the biopharma industry — but leaders around the industry have some ideas to fix it.
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Morning RX: June 8, 2023
Drug Topics
JUNE 8, 2023
A survey shows cancer centers are struggling, Google expands its generative AI into health care, and the WHO announces enhanced collaboration with the Global Fund.
Patient Case Study: A Rare Neurological Disease Diagnostic Journey
Pharmacy Times
JUNE 8, 2023
Neuromyelitis optica spectrum disorder is an autoimmune disease characterized by severe attacks of optic neuritis and/or myelitis, leading to possible visual loss, paralysis, cognitive impairment, sensory deficits, bladder dysfunction, and even mortality.
Signup to get articles personalized to your interests!
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
More Trending
CMS launches new pilot program to test out value-based primary care in 8 states
Fierce Healthcare
JUNE 8, 2023
The Centers for Medicare and Medicaid Services aims to advance value-based primary care, especially in rural areas and among underserved populations, with a new pilot project. | The Centers for Medicare and Medicaid Services aims to advance value-based primary care, especially in rural areas and among underserved populations, with a new pilot project.
FDA’s decentralized trials guidance leaves slate of fresh questions for industry
PharmaVoice
JUNE 8, 2023
Recent FDA guidance aims to bolster DCT adoption but provides little clarity on the patchwork of telemedicine laws that pose an obstacle to the approach.
New Study Suggests Symptoms of Insomnia Linked to Increased Risk of Stroke
Pharmacy Times
JUNE 8, 2023
People with less severe symptoms of insomnia still had a 16% increased risk of stroke compared to people with no symptoms.
For providers, consolidation may be key to staying afloat, experts tell Senators
Fierce Healthcare
JUNE 8, 2023
Consolidation has been the norm across healthcare for some time, and for those in the industry that want to stay independent, watching their peers unite can be intimidating. | Consolidation has been the norm across healthcare for some time, and for those in the industry that want to stay independent, watching their peers unite can be intimidating.
Position Your Pharmacy for Expansion
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Single Tablet Macitentan, Tadalafil Combination for Pulmonary Arterial Hypertension May Improve Patient Quality of Life
Pharmacy Times
JUNE 8, 2023
Positive data from the phase 3 A DUE study demonstrated that the investigational combination therapy of macitentan 10 mg and tadalafil 40 in a single tablet improved pulmonary hemodynamics compared to the same drugs as monotherapies.
AHA: Administrative burdens and payer rates—not hospitals—are to blame for fewer independent physician practices
Fierce Healthcare
JUNE 8, 2023
Hospital acquisitions of physician practices are primarily being fueled by burdensome administrative requirements, rising expenses and insufficient commercial and public reimbursement rates, the in | The American Hospital Association released a report outlining the workload and expenses they say are driving physicians under their wing. The hospital industry lobbyist also floated major acquisitions by CVS Health and UnitedHealth Group's Optum as more deserving targets for policymakers'
Clinical Overview: A Novel Way of Treating Schizophrenia
Pharmacy Times
JUNE 8, 2023
The estimated cost burden of schizophrenia is more than $150 billion, consisting of direct treatment cost and lost productivity.
Cardinal Health’s Outcomes merges into Transaction Data Systems
Drug Store News
JUNE 8, 2023
Cardinal Health's Outcomes business will combine with Transaction Data Systems to offer improved patient engagement and clinical pharmacy solutions.
What the FDA's New Dosage Guidance Means for the Future of Clinical Research
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Public Health Matters - Advocating for Patients, Impacting Public Health
Pharmacy Times
JUNE 8, 2023
Christina Madison speaks with Sandra Leal, PharmD, fromCVS Health, about advocating for patients and how that impacts public health.
ACO sign-ups for 2024 are underway. Policy changes have helped, but more work is needed, experts say
Fierce Healthcare
JUNE 8, 2023
Phase 1 enrollment in the Medicare Shared Savings Program (MSSP) for 2024 is currently underway, and recent reforms hold promise in attracting new providers into accountable care. | Phase 1 enrollment in the Medicare Shared Savings Program for 2024 is currently underway, and recent reforms hold promise in attracting new providers into accountable care.
Teva gets its US opioid settlement over the finish line
pharmaphorum
JUNE 8, 2023
Teva gets its US opioid settlement over the finish line Phil.
Deal of the week: Strive Health raises $166m to aid kidney health services
Pharmaceutical Technology
JUNE 8, 2023
Each week, Pharmaceutical Technology’s editors select a deal that illustrates the themes driving change in our sector. The deal may not always be the largest in value, or the highest profile. But it will tell us where the leading companies are focusing their efforts, and why. This new, thematic deal coverage is driven by our underlying Disruptor data which tracks all major deals, patents, company filings, hiring patterns and social media buzz across our sectors.
5 Reasons to Upgrade Your Pharmacy Management Software
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
STAT+: If AI invents a new medicine, who gets the patent?
STAT
JUNE 8, 2023
Pharmaceutical and biotech companies are increasingly using artificial intelligence to discover and make drugs and therapeutics. Congress on Wednesday asked the question: Does that mean AI can be an inventor on a patent? AI models can already look for patterns in old clinical trial data, look at images of cells and quantify changes in them, or virtually test whether drug candidates will dock in a certain receptor — all with tools that aren’t that different from Excel or a calculato
Show 1343: Hidden Harms of Herb and Drug Interactions
The People's Pharmacy
JUNE 8, 2023
Millions of Americans take dietary supplements, and most of us assume that they are safe. While that is probably a reasonable rule of thumb, there are some situations that require more vigilance. In particular, we need to beware of herb and drug interactions. Even your doctor may not know about the hidden harms. How Risky Are Herb and Drug Interactions?
Opinion: Why brain decoding is not mind reading — and why that matters
STAT
JUNE 8, 2023
Recently, my colleagues and I published a study on decoding language from brain recordings made using functional MRI. Brain decoders are being developed to help restore communication to people who have lost the ability to speak or write. Currently, most brain decoders use recordings from implanted electrodes, and are primarily intended for people with motor system disorders.
Drug Store News holds exclusive beauty forum with top retailers, suppliers
Drug Store News
JUNE 8, 2023
The beauty forum was the first event wholly dedicated to the mass beauty shopper.
STAT+: Study finds supplements of amino acid taurine slow aging in mice and monkeys
STAT
JUNE 8, 2023
The first clue was blind cats. About 50 years ago, K.C. Hayes, a professor of nutrition at the Harvard School of Public Health, took on the mystery of why some cats experienced rapid deterioration of their vision. The problem, Hayes figured out, was that some brands of cat food lacked an amino acid called taurine, something cats don’t produce themselves.
FDA grants orphan drug designation to DTx Pharma’s CMT1A therapeutic
Pharmaceutical Technology
JUNE 8, 2023
The US Food Drug Administration (FDA) has granted orphan drug designation to DTx Pharma’s investigational DTx-1252 for the treatment of Charcot-Marie-Tooth disease Type 1A (CMT1A). DTx-1252 is a fatty acid ligand conjugated oligonucleotides (FALCON) small interfering RNA (siRNA) therapeutic which represses the PMP22 gene in Schwann cells. It induces remyelination of axons to normal levels, increases muscle coordination, agility, mass, grip and strength, and improves electrophysiological measurem
BMI is starting to plateau in rich Western countries. That doesn’t mean obesity is solved
STAT
JUNE 8, 2023
This is part of a series about new obesity drugs that are transforming patients’ lives, dividing medical experts, and spurring one of the biggest business battles in years. Read more about The Obesity Revolution. “S oaring obesity rates.” “An alarming surge in BMI.
2023 Pharm Exec Top 50 Companies
PharmExec
JUNE 8, 2023
With the sales boom from COVID-19 products now in the rear-view, a resetting is underway for those in Pharm Exec’s listing of the top biopharma producers—shifting attention to new Rx roads ahead and the steady strategies needed to navigate a bumpy business terrain.
FDA advisers recommend approval of monoclonal antibody to protect newborns and young children from RSV
STAT
JUNE 8, 2023
A Food and Drug Administration advisory committee voted overwhelmingly on Thursday to recommend approval of a monoclonal antibody product to protect newborns and young children from RSV. The Antimicrobial Drugs Advisory Committee voted unanimously to recommend use of nirsevimab — which will be marketed as Beyfortus — in children in the first year of life.
Multivitamins improve memory, slow cognitive aging in older adults, study finds
Drug Store News
JUNE 8, 2023
The COcoa Supplement and Multivitamin Outcomes Study included two separate clinical trials testing multivitamin supplementation on changes in cognitive function.
STAT+: Pharmalittle: FDA commish calls U.S. drug prices ‘too high’; FDA staff says Eisai and Biogen’s Alzheimer’s drug has benefits
STAT
JUNE 8, 2023
Rise and shine, everyone, another busy day is on the way, although the smoky covering has certainly reduced the number of noisy vehicles that usually pass by at this time of the morning. Nonetheless, there is much to do. So as usual, we are firing up the trusty coffee kettle to brew a cup or three of stimulation. Our choice today is roasted coconut.
AI insight at BIO, Google and Mayo Clinic’s latest effort, & $13 million for health workforce tech
STAT
JUNE 8, 2023
You’re reading the web edition of STAT Health Tech, our guide to how tech is transforming the life sciences. Sign up to get this newsletter delivered in your inbox every Tuesday and Thursday. Psychiatric medications leave many people with mental illness behind. Can AI change that?
Why are rates of HPV vaccination declining globally?
pharmaphorum
JUNE 8, 2023
Why are rates of HPV vaccination declining globally? Mike.
The Need for Speed: Reducing Risk, Cost, and Delays for Novel Gene Therapies
ISPE
JUNE 8, 2023
The Need for Speed: Reducing Risk, Cost, and Delays for Novel Gene Therapies Trudy Patterson Thu, 06/08/2023 - 14:52 iSpeak Blog iSpeak The Need for Speed: Reducing Risk, Cost, and Delays for Novel Gene Therapies Amrit Chaudhuri 8 June 2023 Novel cell and gene therapies are already revolutionizing medicine. These new therapies can modify a patient's DNA and transform their cells into powerful tools for treating a wide range of diseases, from cystic fibrosis and heart disease to diabetes, hemophi
Let's personalize your content